Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OMNIPHYS: A Prospective Multimodal Longitudinal Study of AI-Enabled Physiologic State Modeling and Early Detection of Clinical Deterioration

NCT07814118 is registered in ClinicalTrials.gov with Truway Health, Inc. as lead sponsor.

NCT NCT07814118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07814118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OMNIPHYS: A Prospective Multimodal Longitudinal Study of AI-Enabled Physiologic State Modeling and Early Detection of Clinical Deterioration
Lead sponsor
Truway Health, Inc.
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 2, 2026
Completion date
September 15, 2046
Enrollment
25,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, acute respiratory distress syndrome, aortic diseases, brain aging, brain aging related conditions, brain aneurysm, cardiomyopathies, heart failure, hypertension, muskuloskeletal diseases, myocarditis due to drug, myocarditis viral, myocarditis; acute or subacute, pericardial diseases, peripheral arterial disease, peripheral arterial disease (pad), pulmonary edema - acute, pulmonary edema with heart failure, pulmonary edemas, pulmonary embolism (diagnosis), pulmonary embolism acute, pulmonary embolism acute massive, pulmonary embolism subacute massive, pulmonary hypertension, sepsis, ultrasound, ultrasound exams, ultrasound guidance, valvular heart diseases, venous thrombosis (disorder), venous thrombosis pulmonary, venous thrombosis, deep